Security Snapshot

PROKIDNEY CORP. - Class A Common Stock, par value $0.0001 per share (PROK) Institutional Ownership

CUSIP: 74291D104

13F Institutional Holders and Ownership History from Q2 2025 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

67

Shares (Excl. Options)

42,641,617

Price

$1.79

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Class A Common Stock, par value $0.0001 per share
Symbol
PROK on Nasdaq
Shares outstanding
205,118,675
Price per share
$1.82
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
42,641,617
Total reported value
$76,327,899
% of total 13F portfolios
0%
Share change
+622,365
Value change
+$940,293
Number of holders
67
Price from insider filings
$1.82
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • PROK - PROKIDNEY CORP. - Class A Common Stock, par value $0.0001 per share is tracked under CUSIP 74291D104.
  • 67 institutions reported positions in Q1 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 61 to 67 between Q4 2025 and Q1 2026.
  • Reported value moved from $93,956,490 to $76,327,899.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 67 institutions filings for Q1 2026.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 74291D104?
CUSIP 74291D104 identifies PROK - PROKIDNEY CORP. - Class A Common Stock, par value $0.0001 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.

Significant Owners of PROKIDNEY CORP. - Class A Common Stock, par value $0.0001 per share (PROK) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Control Empresarial de Capitales S.A. de C.V. 36% $132,052,942 73,842,723 Control Empresarial de Capitales S.A. de C.V. 28 Apr 2026
MORGAN STANLEY 6% $19,510,759 8,519,982 Morgan Stanley 31 Dec 2025

As of 31 Mar 2026, 67 institutional investors reported holding 42,641,617 shares of PROKIDNEY CORP. - Class A Common Stock, par value $0.0001 per share (PROK). This represents 21% of the company’s total 205,118,675 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of PROKIDNEY CORP. - Class A Common Stock, par value $0.0001 per share (PROK) together control 20% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
SUVRETTA CAPITAL MANAGEMENT, LLC 6% 12,341,266 0% 0.6% $22,090,866
MORGAN STANLEY 4.4% 8,955,967 +1.6% 0% $16,031,179
MILLENNIUM MANAGEMENT LLC 1.1% 2,271,577 +24% 0% $4,066,123
Bleichroeder LP 0.98% 2,000,000 0% 0.62% $3,580,000
Artia Global Partners LP 0.88% 1,806,939 -1.7% 0.73% $3,234,421
Hennion & Walsh Asset Management, Inc. 0.79% 1,611,693 +7.2% 0.1% $2,884,930
BlackRock, Inc. 0.68% 1,387,116 -1.2% 0% $2,482,938
RENAISSANCE TECHNOLOGIES LLC 0.61% 1,250,794 +40% 0% $2,238,921
GEODE CAPITAL MANAGEMENT, LLC 0.6% 1,230,409 +2.7% 0% $2,203,520
VANGUARD CAPITAL MANAGEMENT LLC 0.56% 1,146,937 0% 0% $2,053,017
MARSHALL WACE, LLP 0.49% 1,011,744 +65% 0% $1,811,023
BANK OF AMERICA CORP /DE/ 0.37% 753,412 +6.7% 0% $1,348,607
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.31% 627,771 +0.75% 0% $1,123,710
STATE STREET CORP 0.27% 556,845 +16% 0% $996,753
VANGUARD FIDUCIARY TRUST CO 0.26% 538,371 0% 0% $963,684
Woodline Partners LP 0.24% 500,000 0% 0% $895,000
MYDA Advisors LLC 0.21% 428,775 -2.6% 0.18% $767,507
GOLDMAN SACHS GROUP INC 0.21% 421,902 -38% 0% $755,204
TWO SIGMA INVESTMENTS, LP 0.17% 346,382 -26% 0% $620,024
UBS Group AG 0.16% 334,546 -20% 0% $598,837
Amundi 0.14% 291,708 +7.2% 0% $522,157
JANE STREET GROUP, LLC 0.13% 264,285 -46% 0% $473,070
ExodusPoint Capital Management, LP 0.12% 254,353 +97% 0% $455,292
NORTHERN TRUST CORP 0.12% 241,580 0% 0% $432,428
Squarepoint Ops LLC 0.1% 211,107 -40% 0% $377,882

Institutional Holders of PROKIDNEY CORP. - Class A Common Stock, par value $0.0001 per share (PROK) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 42,641,617 $76,327,899 +$940,293 $1.79 67
2025 Q4 41,944,849 $93,956,490 +$18,974,610 $2.24 61
2025 Q3 33,452,097 $80,954,450 +$79,786,213 $2.42 55
2025 Q2 527,620 $311,428 +$311,428 $0.59 5
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .